Royce & Associates LP grew its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 8.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 202,981 shares of the business services provider's stock after buying an additional 15,255 shares during the period. Royce & Associates LP owned 0.40% of Exponent worth $18,086,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. State Street Corp raised its holdings in shares of Exponent by 0.7% in the third quarter. State Street Corp now owns 1,840,313 shares of the business services provider's stock worth $212,151,000 after buying an additional 13,644 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Exponent by 4.8% during the third quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider's stock worth $173,597,000 after purchasing an additional 69,099 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Exponent by 63.6% during the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after purchasing an additional 245,086 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of Exponent during the fourth quarter worth $55,131,000. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Exponent by 1.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 525,378 shares of the business services provider's stock worth $46,811,000 after purchasing an additional 7,766 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.
Insider Buying and Selling
In other Exponent news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now owns 1,800 shares of the company's stock, valued at approximately $154,674. The trade was a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.10% of the stock is currently owned by corporate insiders.
Exponent Stock Performance
Shares of Exponent stock traded down $2.02 during trading on Thursday, hitting $80.22. 332,236 shares of the company's stock were exchanged, compared to its average volume of 215,502. The business has a 50-day simple moving average of $88.22 and a 200-day simple moving average of $96.90. Exponent, Inc. has a 52-week low of $77.30 and a 52-week high of $115.75. The stock has a market capitalization of $4.08 billion, a price-to-earnings ratio of 37.84 and a beta of 0.77.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the previous year, the firm earned $0.41 earnings per share. On average, equities analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.